Earnings History Data for Annexon (ANNX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Annexon

Annexon Inc. is a clinical-stage biopharmaceutical company. It engages in developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company's product candidate includes ANX005 and ANX007, which are in clinical stage. Annexon Inc. is based in SAN FRANCISCO, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2024	PM		ANNX	Annexon	698.00	-0.25	-0.26	0.00	Annexon Biosciences GAAP EPS of -$0.25 beats by $0.03 [11/14/2024 3:27 PM]	6.32	-0.23 (-3.51%)	6.55	0.0 (0.00%)	2.27 - 8.40	594,012	1,530,000	150,862
Annexon Biosciences GAAP EPS of -$0.25 beats by $0.03 [11/14/2024 3:27 PM] Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones [2024-11-14 08:00AM] Annexon Biosciences to Present at the Jefferies London Healthcare Conference [Nov-13-24 04:05PM]
13-11-2023	PM		ANNX	Annexon	110.00	-0.43	-0.50	0.00	Annexon GAAP EPS of -$0.43 beats by $0.07 [11/13/2023 6:39 AM]	2.27	0.14 (6.59%)	0.0	0.0 (0.00%)	1.57 - 7.65	167,001	290,000	0
Annexon GAAP EPS of -$0.43 beats by $0.07 [11/13/2023 6:39 AM]
07-08-2023	PM		ANNX	Annexon	186.00	-0.47	-0.54	0.00	Annexon Biosciences GAAP EPS of -$0.47 beats by $0.07 [8/7/2023 6:50 AM]	3.45	0.07 (2.07%)	3.40	0.02 (0.59%)	2.07 - 7.65	355,039	620,000	231
Annexon Biosciences GAAP EPS of -$0.47 beats by $0.07 [8/7/2023 6:50 AM]
06-03-2023	PM		ANNX	Annexon	241.00	-0.48	-0.52	0.00	Annexon Biosciences GAAP EPS of -$0.48 beats by $0.05 [3/6/2023 6:46 AM]	4.42	-0.31 (-6.55%)	4.68	-0.05 (-1.06%)	2.06 - 7.65	492,690	670,000	747
Annexon Biosciences GAAP EPS of -$0.48 beats by $0.05 [3/6/2023 6:46 AM]
03-11-2022	PM		ANNX	Annexon	225.00	-0.51	-0.87	0.00	Annexon Biosciences GAAP EPS of -$0.51 beats by $0.35 [11/3/2022 9:23 AM]	4.67	0.04 (0.86%)	0.0	0.0 (0.00%)	2.06 - 18.06	36,850	130,000	0
Annexon Biosciences GAAP EPS of -$0.51 beats by $0.35 [11/3/2022 9:23 AM] Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023 [Nov-03-22 06:30AM]
08-08-2022	AH		ANNX	Annexon	194.00	-0.96	-0.94	0.00	Annexon Biosciences GAAP EPS of -$0.96 misses by $0.02 [8/8/2022 5:24 PM]	5.40	0.17 (3.25%)	5.28	0.05 (0.96%)	2.06 - 23.61	287,600	170,000	1,197
Annexon Biosciences GAAP EPS of -$0.96 misses by $0.02 [8/8/2022 5:24 PM] Annexon Biosciences Highlights Business and Portfolio Progress and Key Anticipated Milestones and Reports Second Quarter 2022 Financial Results [Aug-08-22 04:01PM]
09-05-2022	AH		ANNX	Annexon	102.00	-0.92	-1.00	0.00	Annexon Biosciences GAAP EPS of -$0.92 beats by $0.08 [5/9/2022 5:27 PM]	3.22	0.62 (23.86%)	2.60	0.0 (0.00%)	2.06 - 24.85	1,343,109	610,000	2,033
Annexon Biosciences GAAP EPS of -$0.92 beats by $0.08 [5/9/2022 5:27 PM] Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial Results [May-09-22 04:01PM]
01-03-2022	AH	4:00 PM ET (Mar 1)	ANNX	Annexon	197.00	-0.97	-0.90	0.00	Annexon Biosciences GAAP EPS of -$0.97 misses by $0.05 [3/1/2022 5:05 PM]	4.61	-0.12 (-2.54%)	4.73	0.0 (0.00%)	4.56 - 35.99	657,484	310,000	2,676
Annexon Biosciences GAAP EPS of -$0.97 misses by $0.05 [3/1/2022 5:05 PM] Annexon Biosciences Announces Program Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-01-22 04:01PM] Annexon Biosciences to Participate in the Cowen 42nd Annual Healthcare Conference [Feb-28-22 06:30AM]
09-11-2021	AH	4:00 PM ET (Nov 9)	ANNX	Annexon	595.00	-0.93	-0.88	0.00	Annexon Biosciences EPS misses by $0.06 [11/9/2021 5:07 PM]	16.63	0.23 (1.40%)	16.40	0.0 (0.00%)	14.73 - 38.01	130,324	220,000	15,060
Annexon Biosciences EPS misses by $0.06 [11/9/2021 5:07 PM] Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results [Nov-09-21 04:01PM]
16-08-2021	AH		ANNX	Annexon, Inc.	755.00	-0.82	-0.68	0.00	Annexon Biosciences EPS misses by $0.13 [8/16/2021 4:43 PM]	18.45	-0.54 (-2.84%)	18.99	0.0 (0.00%)	17.27 - 38.01	104,278	100,000	3,109
Annexon Biosciences EPS misses by $0.13 [8/16/2021 4:43 PM] Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update [Aug-16-21 04:01PM]
17-05-2021	AH		ANNX	Annexon, Inc.	754.00	-0.68	-0.60	0.00	Annexon Biosciences EPS misses by $0.07 [5/17/2021 5:02 PM]	20.75	-0.01 (-0.05%)	20.76	0.0 (0.00%)	15.33 - 38.01	151,755	200,000	4,344
Annexon Biosciences EPS misses by $0.07 [5/17/2021 5:02 PM] Annexon Biosciences Provides Business Update and Reports First Quarter 2021 Financial Results [May-17-21 04:05PM]
25-03-2021	PM	Before the open (Mar 25)	ANNX	Annexon, Inc.	1,120	-0.61	-0.42	0.00	Annexon Biosciences reports Q4 results [3/25/2021 7:24 AM]	28.99	-0.93 (-3.11%)	29.92	0.0 (0.00%)	15.33 - 38.01	176,398	340,000	1,580
Annexon Biosciences reports Q4 results [3/25/2021 7:24 AM] Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results with Recent Business Highlights [Mar-25-21 07:00AM]